Biogen — Drug Prices & Medicare Spending
Biogen manufactures 6 drugs tracked by Medicare Part D with total spending of $5.4B.
6
Drugs Tracked
$5.4B
Medicare Spending
$6,215.10
Avg Cost/Claim
100%
Have Generics
Biogen Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Tecfidera | Dimethyl Fumarate | $4,103.00 | Yes |
| 2 | Tysabri | Natalizumab | $9,952.00 | Yes |
| 3 | Vumerity | Diroximel Fumarate | $4,710.00 | Yes |
| 4 | Spinraza | Nusinersen | $73,000.00 | Yes |
| 5 | Avonex | Interferon Beta-1a | $5,074.00 | Yes |
| 6 | Plegridy | Peginterferon Beta-1a | $6,161.00 | Yes |
Frequently Asked Questions
Biogen manufactures 6 drugs tracked by Medicare Part D, with total annual spending of $5.4B.
Spinraza (Nusinersen) is the most expensive at $73,000.00 per claim.
6 of 6 Biogen drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.